There are many other clinical manifestations that may be included, such as menstrual irregularities, signs of androgen excess, obesity, insulin resistance, elevated serum levels of LH, increased risk of type 2 diabetes [98], and cardiovascular events [99]. This evidence concerns the gene PLOD1 and obesity due to melanocortin 4 receptor deficiency.